The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
A phase II clinical trial to study the use of cabozantinib (cabo) in patients with hepatocellular carcinoma (HCC) post immunotherapy treatment.
 
Stephen Lam Chan
Honoraria - AstraZeneca; Eisai; Ipsen; MSD; Roche
Consulting or Advisory Role - AstraZeneca; BMS; Eisai; MSD Oncology; Roche
Research Funding - Bayer; Eisai; Ipsen; MSD; Sirtex Medical
 
Baek-Yeol Ryoo
No Relationships to Disclose
 
Frankie Mo
No Relationships to Disclose
 
Jaekyung Cheon
No Relationships to Disclose
 
Leung Li
No Relationships to Disclose
 
Kwan H. Wong
No Relationships to Disclose
 
Nicole Yim
No Relationships to Disclose
 
Hyeyeong Kim
No Relationships to Disclose
 
Changhoon Yoo
Honoraria - AstraZeneca; Bayer; Bristol-Myers Squibb; Eisai; Ipsen; MSD Oncology; SERVIER
Speakers' Bureau - Bayer; Celgene; Eisai; Ipsen; Merck Sharp & Dohme; Novartis
Research Funding - AstraZeneca; Bayer; CKD pharm; SERVIER